Skip to main content
SpringerLink
Log in

Fuzheng Huayu Capsule (扶正化瘀胶囊) in the treatment of liver fibrosis: Clinical evidence and mechanism of action

  • Review
  • Published:
Chinese Journal of Integrative Medicine Aims and scope Submit manuscript

Abstract

Liver fibrosis represents the wound healing response to liver injury from a wide variety of etiologies. Remarkable progresses have been shown in the field of liver fibrosis in a range of areas in the past years. In particular, the reversibility of liver fibrosis has been well documented in both patients and animal models. Great progresses have been made in the treatment of liver fibrosis with Chinese medicine. This review summarizes the effects of Fuzheng Huayu Capsule (扶正化瘀胶囊, FZHYC) in treating liver fibrosis and inflammation induced by chronic hepatitis B in clinical trials and the mechanism of action of FZHYC in reversing liver fibrosis in vivo and in vitro experiments.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References

  1. Friedman SL. Liver fibrosis — from bench to bedside. J Hepatol 2003; (38 Suppl 1):S38–S53.

  2. Friedman SL. Reversibility of hepatic fibrosis and cirrhosis—is it all hype? Nat Clin Pract Gastroenterol Hepatol 2007;4:236–237.

    Article  PubMed  Google Scholar 

  3. Wang HJ, Wang BE. The long-term therapeutic efficacy of compound Radix Salvia Miltiorrhiza Granule (861 Granule) in treating liver fibrosis. Chin J Integr Tradit West Med Liver Dis (Chin) 1995;5:4–5

    Google Scholar 

  4. Liu P, Liu C, Hu YY. Effect of Fuzheng Huayu Recipe in treating posthepatitic cirrhosis. Chin J Integr Tradit West Med (Chin) 1996;16:459–462.

    CAS  Google Scholar 

  5. Special Committee of Liver Diseases, Chinese Association of Integrative Medicine, Guideline for the diagnosis and treatment of liver fibrosis with integrative medicine. Chin J Integr Tradit West Med (Chin) 2006;26:1052–1056.

    Google Scholar 

  6. Wang YR. Review and prospect of traditional Chinese medicine in the treatment of advanced schistosome cirrhosis. Shanghai J Tradit Chin Med (Chin) 1985;6:7–10.

    CAS  Google Scholar 

  7. Xu LM, Liu P, Liu CH. Pathological and immunohistochemical study of extractum semen persiae and cordyceps hyphae in treating posthepatitic cirrhosis. J Tradit Chin Med (Chin) 1994;35:737–739.

    CAS  Google Scholar 

  8. Liu P, Liu C, Chen GC, Hu YY, Xu LM, Lv P, et al. Effect of Fuzheng Huayu 319 Recipe on serological parameters of fibrosis in treating chronic hepatitis B. Chin J Integr Tradit West Med (Chin) 1996;16:588–592.

    Google Scholar 

  9. Xu LM, Liu P, Liu C, Gu HT, Xue HM, Lv G, et al. Treatment of chronic hepatitis B and liver fibrosis with Fuzheng Huayu 319 Recipe. Chin J Hepatol (Chin) 1997; 5:207–209.

    Google Scholar 

  10. Liu P, Hu YY, Liu C, Zhu DY, Xue HM, Xu ZQ, et al. Clinical observation of salvianolic acid B in treatment of liver fibrosis in chronic hepatitis B. World J Gastroenterol 2002;8:679–685.

    PubMed  CAS  Google Scholar 

  11. Liu P, Hu YY, Liu C, Xu LM, Liu CH, Sun KW, et al. Multicenter clinical study on Fuzheng Huayu Capsule against liver fibrosis due to chronic hepatitis B. World J Gastroenterol 2005;11:2892–2899.

    PubMed  CAS  Google Scholar 

  12. Hu YY, Liu P, Liu C, Liu CH, Xu LM. The value of serum markers in evaluating liver fibrotic changes. Chin J Hepatol (Chin) 2006;14:174–177.

    CAS  Google Scholar 

  13. Liu CH, Wang XL, Liu P. Serapharmacological effect of Fuzheng Huayu 319 Decoction on expression of type I collagen and transforming growth factor β 1 in hepatic stellate cells. Chin J Integr Tradit West Med (Chin) 1999;19:412–414.

    CAS  Google Scholar 

  14. Zhou T, Yan XC, Chen Q, Tao YY, Liu CH. Effect of Fuzheng Huayu Decoction on hepatocytic apoptosis and necrosis on acute hepatotoxin due to LPS in mice. Drug Eval (Chin) 2008;5:204–208.

    Google Scholar 

  15. Jiang CM, Liu C, Liu CH, Hu YY. Effect of Fuzheng Huayu Decoction (FZHYF) on the function of Kupffer cells from acute injury liver induced by CCl4. Chin J Integr Tradit West Med Liver Dis (Chin) 2000;10 (5):26–28.

    Google Scholar 

  16. Lu X, Liu P, Liu CH, Xu GF, Wang XB, et al. Role of hepatic sinusoidal endothelium injury in hepatic fibrogenesis induced by dimethylnitrosamine in rats. Chin J Hepatol (Chin) 2002;10:441–444.

    CAS  Google Scholar 

  17. Lu X, Liu P, Liu CH, Xu GF, Li FH, Gu HT, et al. Experimental study for role of Fu Zheng Hua Yu Recipe on promoting reversion of hepatic sinusoid capillarization induced by dimethylnitrosamine in rats. J Chin Med (Chin) 2003;44:136–139.

    Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Shanghai University of Traditional Chinese Medicine, Shanghai, 201203, China

    Ping Liu  (刘 平)

Authors
  1. Ping Liu  (刘 平)
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Ping Liu  (刘 平).

Rights and permissions

Reprints and permissions

About this article

Cite this article

Liu, P. Fuzheng Huayu Capsule (扶正化瘀胶囊) in the treatment of liver fibrosis: Clinical evidence and mechanism of action. Chin. J. Integr. Med. 18, 398–400 (2012). https://doi.org/10.1007/s11655-012-1030-1

Download citation

  • Received:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s11655-012-1030-1

Keywords

Search

Navigation